In the News

2017-11-02 – Labiotech.eu

German Biotech Pockets €18M in its Series A to Propel Autoimmune Disease Candidate Forward

Topas Therapeutics received an extra €4M from Boehringer Ingelheim Venture Fund to help its autoimmune disease candidates accelerated through trials.

By Alex Dale


2017-08-22 – BioCentury Extra, August 22, 2017

Lilly backs Topas’ liver-specific nanoparticles platform

COMPANY NEWS by Elizabeth S. Eaton

read more …

2016-05-21 – Bioworld Today, May 21, 2016, p 1, 8

Evotec spinout Topas takes targeted aim at autoimmune diseases

NEWCO NEWS by Nuala Moran, Staff Writer, p 1, 8

read more …

2016-05-09 – Biocentury, May 9, 2016, p12

Deliver to the liver

Emerging Company Profile by Steve Edelson, Senior Editor

read more …